We serve Chemical Name:S-ethyl chloridothiocarbonate CAS:2941-64-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:S-ethyl chloridothiocarbonate
CAS.NO:2941-64-2
Synonyms:S-ethyl thiochloroformate;Ethyl thiochloroformate;MFCD00037110;S-ETHYL CHLOROTHIOLFORMATE;EINECS 220-928-1;Carbonochloridothioic acid, S-ethyl ester;Ethylthiol chloroformate;ethyl chlorothiolformate;chlorothioformic acid-S-ethyl ester;Ethyl chlorothioformate;S-ethyl chloridothiocarbonate;S-Ethyl chlorothioformate;S-Ethyl carbonochloridothioate;Carbonochloridothioic acid,S-ethyl ester
Molecular Formula:C3H5ClOS
Molecular Weight:124.589
HS Code:29159080
Physical and Chemical Properties:
Melting point:-60 °C
Boiling point:132.0±9.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.485
PSA:42.37000
Exact Mass:123.974960
LogP:2.02
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2826 8/PG 2
Packing Group:II
Contact us for information like S-ethyl thiochloroformate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carbonochloridothioic acid,S-ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00037110 Use and application,Ethyl chlorothioformate technical grade,usp/ep/jp grade.
Related News: Importance of evaluating biocatalytic processes during development O3′-(N-benzyloxycarbonyl-phenylalanyl)-O5′-(4-methoxy-trityl)-adenosine manufacturers Importance of evaluating biocatalytic processes during development 1-methyl-4-[(4-pentylphenoxy)methyl]benzene suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 3,4,5-trimethoxy-N-[4-[[2-(4-methylphenyl)imino-4-oxo-1,3-thiazolidin-3-yl]carbamoyl]phenyl]benzamide vendor & factory EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML).,EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML).
